Drug information for ADDERALL 10
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET; ORAL
2.5MG;2.5MG;2.5MG;2.5MG
Discontinued
AMPHETAMINE ASPARTATE
;
AMPHETAMINE SULFATE
;
DEXTROAMPHETAMINE SACCHARATE
;
DEXTROAMPHETAMINE SULFATE
Amphetamine
TEVA WOMENS
11522
2007-06-14 Letter
2007-06-12 Label
2007-05-31 Other Important Information from FDA
2006-07-27 Label
2006-07-27 Label
2006-07-27 Letter
2006-07-27 Letter
2005-08-04 Label
2005-08-04 Label
2005-08-04 Letter
2005-08-04 Letter
2004-04-14 Review
2002-11-08 Letter
2000-06-12 Review
Drug Adverse Effects information for ADDERALL 10
Role code
Indications
Reaction
# Reports
PS
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
DRUG EFFECT DECREASED
1
PS
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
PRODUCT SUBSTITUTION ISSUE
1
PS
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
WEIGHT DECREASED
1
PS
DISTURBANCE IN ATTENTION
DEPRESSION
1
PS
DISTURBANCE IN ATTENTION
DISTURBANCE IN SOCIAL BEHAVIOUR
1
PS
DISTURBANCE IN ATTENTION
DRUG EFFECT DECREASED
1
PS
DISTURBANCE IN ATTENTION
IMPULSIVE BEHAVIOUR
1
PS
DISTURBANCE IN ATTENTION
INSOMNIA
1
PS
DISTURBANCE IN ATTENTION
LOGORRHOEA
1
PS
DISTURBANCE IN ATTENTION
NEGATIVISM
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
ANAPHYLACTIC REACTION
1
PS
STRESS
WEIGHT DECREASED
1
SS
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
AGGRESSION
2
SS
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
CRYING
2
SS
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
INSOMNIA
2
SS
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
IRRITABILITY
2
SS
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
UNDERWEIGHT
2
SS
DRUG DEPENDENCE
ABDOMINAL PAIN
1
SS
DRUG DEPENDENCE
AGGRESSION
1
SS
DRUG DEPENDENCE
DRUG WITHDRAWAL SYNDROME
1
SS
DRUG DEPENDENCE
RECTAL HAEMORRHAGE
1
SS
DRUG DEPENDENCE
SUBSTANCE USE
1
SS
SUBSTANCE USE
ABDOMINAL PAIN
2
SS
SUBSTANCE USE
AGGRESSION
2
SS
SUBSTANCE USE
DRUG WITHDRAWAL SYNDROME
2
SS
SUBSTANCE USE
RECTAL HAEMORRHAGE
2
SS
SUBSTANCE USE
SUBSTANCE USE
2
C
ANTACID THERAPY
RESPIRATORY DISTRESS
1
C
ANXIETY DISORDER
RESPIRATORY DISTRESS
1
C
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
RESPIRATORY DISTRESS
1
C
FATIGUE
FATIGUE
1
C
FATIGUE
PYREXIA
1
C
MULTIPLE SCLEROSIS
ABDOMINAL DISTENSION
2
C
MULTIPLE SCLEROSIS
ABDOMINAL PAIN
3
C
MULTIPLE SCLEROSIS
ABDOMINAL PAIN UPPER
1
C
MULTIPLE SCLEROSIS
ALANINE AMINOTRANSFERASE INCREASED
1
C
MULTIPLE SCLEROSIS
ARTHRALGIA
1
C
MULTIPLE SCLEROSIS
ASPARTATE AMINOTRANSFERASE INCREASED
1
C
MULTIPLE SCLEROSIS
ASTHENIA
3
C
MULTIPLE SCLEROSIS
ATRIOVENTRICULAR BLOCK FIRST DEGREE
1
C
MULTIPLE SCLEROSIS
BALANCE DISORDER
2
C
MULTIPLE SCLEROSIS
CENTRAL NERVOUS SYSTEM LESION
1
C
MULTIPLE SCLEROSIS
CHEST DISCOMFORT
1
C
MULTIPLE SCLEROSIS
CONDUCTION DISORDER
1
C
MULTIPLE SCLEROSIS
COUGH
2
C
MULTIPLE SCLEROSIS
DIARRHOEA
2
C
MULTIPLE SCLEROSIS
DIPLOPIA
2
C
MULTIPLE SCLEROSIS
DIZZINESS
2
C
MULTIPLE SCLEROSIS
DYSPEPSIA
1
C
MULTIPLE SCLEROSIS
DYSPNOEA
2
C
MULTIPLE SCLEROSIS
ELECTROCARDIOGRAM PR PROLONGATION
1
C
MULTIPLE SCLEROSIS
ERUCTATION
2
C
MULTIPLE SCLEROSIS
FATIGUE
8
C
MULTIPLE SCLEROSIS
FEELING ABNORMAL
2
C
MULTIPLE SCLEROSIS
GAIT DISTURBANCE
1
C
MULTIPLE SCLEROSIS
GASTROINTESTINAL PAIN
2
C
MULTIPLE SCLEROSIS
GASTROOESOPHAGEAL REFLUX DISEASE
2
C
MULTIPLE SCLEROSIS
HEADACHE
2
C
MULTIPLE SCLEROSIS
HEART RATE DECREASED
4
C
MULTIPLE SCLEROSIS
HEART RATE IRREGULAR
1
C
MULTIPLE SCLEROSIS
HYPOAESTHESIA
1
C
MULTIPLE SCLEROSIS
INCORRECT DOSE ADMINISTERED
1
C
MULTIPLE SCLEROSIS
LIVER FUNCTION TEST ABNORMAL
1
C
MULTIPLE SCLEROSIS
MACULAR OEDEMA
1
C
MULTIPLE SCLEROSIS
MEMORY IMPAIRMENT
1
C
MULTIPLE SCLEROSIS
MULTIPLE SCLEROSIS RELAPSE
2
C
MULTIPLE SCLEROSIS
MUSCULAR WEAKNESS
1
C
MULTIPLE SCLEROSIS
MUSCULOSKELETAL PAIN
2
C
MULTIPLE SCLEROSIS
NAUSEA
2
C
MULTIPLE SCLEROSIS
PAIN IN EXTREMITY
1
C
MULTIPLE SCLEROSIS
PERIPHERAL SENSORIMOTOR NEUROPATHY
1
C
MULTIPLE SCLEROSIS
PYREXIA
1
C
MULTIPLE SCLEROSIS
SALIVARY HYPERSECRETION
1
C
MULTIPLE SCLEROSIS
SENSATION OF PRESSURE
1
C
MULTIPLE SCLEROSIS
SINUSITIS
1
C
MULTIPLE SCLEROSIS
TOXIC ENCEPHALOPATHY
1
C
MULTIPLE SCLEROSIS
UPPER RESPIRATORY TRACT INFECTION
1
C
MULTIPLE SCLEROSIS
URINARY TRACT INFECTION
1
C
MULTIPLE SCLEROSIS
VERTIGO
1
C
MULTIPLE SCLEROSIS
VISUAL IMPAIRMENT
2
C
MULTIPLE SCLEROSIS
VITAMIN D INCREASED
1
C
MULTIPLE SCLEROSIS
VOMITING
1
C
MULTIPLE SCLEROSIS
WHITE BLOOD CELL COUNT DECREASED
1
C
PROPHYLAXIS AGAINST TRANSPLANT REJECTION
PANCREATITIS
2
C
PSYCHOTIC DISORDER
RESPIRATORY DISTRESS
2
C
RELAPSING-REMITTING MULTIPLE SCLEROSIS
BLOOD PRESSURE INCREASED
1
C
RELAPSING-REMITTING MULTIPLE SCLEROSIS
DIZZINESS
1
C
RELAPSING-REMITTING MULTIPLE SCLEROSIS
HEADACHE
1
C
TYPE 2 DIABETES MELLITUS
CHOLELITHIASIS
1
C
TYPE 2 DIABETES MELLITUS
PANCREATITIS
1
C
TYPE 2 DIABETES MELLITUS
WEIGHT DECREASED
1
C
VITAMIN SUPPLEMENTATION
RESPIRATORY DISTRESS
1
Ads by Google